Intra-Cellular Therapies Inc. buy Bank of America Co.
Start price
18.04.24
/
50%
€68.50
Target price
18.04.25
€85.29
Performance (%)
5.84%
Price
22:26
€72.50
Summary
This prediction is currently active. The BUY prediction by Bank_of_America_Co_ shows slight gains of 5.84%. This prediction currently runs until 18.04.25. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intra-Cellular Therapies Inc. | 7.971% | 7.971% |
iShares Core DAX® | 1.280% | 1.027% |
iShares Nasdaq 100 | -2.457% | -4.650% |
iShares Nikkei 225® | -2.006% | -2.091% |
iShares S&P 500 | -0.662% | -1.246% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Bank of America Co. from $82.00 to $91.00. They now have a "buy" rating on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€63.50
02.01.24
02.01.24
€74.81
02.01.25
02.01.25
14.17%
22:26
22:26
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€52.40
29.03.23
29.03.23
€58.10
29.03.24
29.03.24
22.14%
30.03.24
30.03.24